The European Medicines Agency recommended that CSL Ltd.’s drug Tavneos be pulled from the market after finding it was approved based on allegedly incorrect and misleading data, according to Bloomberg.
The move adds pressure to US manufacturer Amgen Inc.
Europe Backs Withdrawal of CSL’s Tavneos After Data Integrity Questions
2026-06-26 12:48:02
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Binance Wallet to Launch DeFi Earn Week Season 2 With Two Promotions and Reward PoolsNext article：
美股大型科技股盘前涨跌不一
